Mohammadi Khadije, Soltani Parya, Davari Nazanin
Cardiovascular Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Department of Radiology, Kerman University of Medical Sciences, Kerman, Iran.
J Cardiovasc Thorac Res. 2023;15(2):127-130. doi: 10.34172/jcvtr.2023.31618. Epub 2023 Jun 29.
COVID-19 has been known to induce systemic inflammation and hyper coagulate state leading to different complications. Cardiovascular complications are one of the most important among complications following COVID-19 infection. A 57 years old woman with past medical history of COVID-19 infection about two months ago came to our hospital with presentation of fever and dyspnea. During workup, tricuspid valve infection associated with pulmonary septic emboli was diagnosed without any obvious risk factor for infective endocarditis. It seems that COVID-19 infection may increase the rate of endocarditis in patients with or without risk factors of endocarditis.
已知新冠病毒病(COVID-19)可引发全身炎症和高凝状态,进而导致不同并发症。心血管并发症是COVID-19感染后并发症中最重要的并发症之一。一名57岁女性,约两个月前有COVID-19感染病史,因发热和呼吸困难前来我院就诊。在检查过程中,诊断出三尖瓣感染合并肺脓毒性栓子,且无任何明显的感染性心内膜炎危险因素。看来,COVID-19感染可能会增加有或无感染性心内膜炎危险因素患者的心内膜炎发生率。